Potent and selective antiviral activity of a new nucleoside analog (NSC-614846) against human immunodeficiency virus (HIV) in vitro: R. Vince, M. Hua, J. Brownell, W. M. Shannon, G.C. Lavelle, K.J. Qualls, O. Weislow, R. Kiser, R. Schultz, R.H. Shoemaker, J.G. Mayo, M.R. Boyd, and P.G. Canonico. University of Minnesota, Minneapolis, MN 55455 USA, Southern Research Institute, Birmingham, AL 35255 USA, Program Resources, Inc., Frederick, MD 21701 USA, National Cancer Institute, Bethesda, MD 20892 USA, Frederick Cancer Research Facility, NCI, Frederick, MD 21701 USA, and U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD 21701 USA